We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
1001
DELISTED
Hologic
HOLX
| $3.04M | 0.01% |
+58,200
| New | +$2.9M |
|
1002
HEICO Corp
HEI
$51B
| $3.04M | 0.01% |
+26,601
| New | +$3.27M |
|
1003
Champion Homes
SKY
$5.05B
| $3.02M | 0.01% |
95,222
+78,922
| +484% | +$2.46M |
|
1004
Goldman Sachs
GS
$301B
| $3.01M | 0.01% |
13,100
-159,400
| -92% | -$34.6M |
|
1005
Kosmos Energy
KOS
$1.51B
| $3.01M | 0.01% |
+528,000
| New | +$3.19M |
|
1006
Barrett Business Services
BBSI
$784M
| $3.01M | 0.01% |
133,068
+87,396
| +191% | +$1.94M |
|
1007
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $3M | 0.01% |
66,851
-24,926
| -27% | -$1.07M |
|
1008
Skywest
SKYW
$4.19B
| $2.99M | 0.01% |
46,210
+23,532
| +104% | +$1.43M |
|
|
LTM
1009
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $2.99M | 0.01% |
+293,895
| New | +$3.28M |
|
|
PRNB
1010
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.98M | 0.01% |
+54,349
| New | +$2.03M |
|
1011
Clarus
CLAR
$147M
| $2.98M | 0.01% |
220,378
-111,346
| -34% | -$1.37M |
|
1012
Hanmi Financial
HAFC
$933M
| $2.97M | 0.01% |
148,464
+17,369
| +13% | +$335K |
|
1013
APA Corp
APA
$14.3B
| $2.94M | 0.01% |
114,700
-680,230
| -86% | -$15.4M |
|
|
BSMX
1014
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $2.93M | 0.01% |
+432,167
| New | +$2.87M |
|
|
RDUS
1015
DELISTED
Radius Health, Inc.
RDUS
| $2.93M | 0.01% |
145,314
+121,900
| +521% | +$2.96M |
|
|
GLOP
1016
DELISTED
GASLOG PARTNERS LP
GLOP
| $2.92M | 0.01% |
186,950
+75,357
| +68% | +$1.31M |
|
1017
Daktronics
DAKT
$1.04B
| $2.92M | 0.01% |
479,133
-36,677
| -7% | -$245K |
|
1018
Standex International
SXI
$4.01B
| $2.91M | 0.01% |
36,699
+12,100
| +49% | +$920K |
|
|
LGTY
1019
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $2.91M | 0.01% |
195,540
-12,891
| -6% | -$203K |
|
1020
Barings BDC
BBDC
$973M
| $2.91M | 0.01% |
282,870
+269,410
| +2,002% | +$2.76M |
|
|
GPOR
1021
DELISTED
Gulfport Energy Corp.
GPOR
| $2.9M | 0.01% |
953,946
+681,600
| +250% | +$1.94M |
|
|
LTRPA
1022
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $2.89M | 0.01% |
+393,735
| New | +$3.17M |
|
|
TBRG
1023
DELISTED
TruBridge
TBRG
| $2.88M | 0.01% |
108,969
+98,469
| +938% | +$2.46M |
|
1024
Lexicon Pharmaceuticals
LXRX
$1.09B
| $2.87M | 0.01% |
+692,603
| New | +$2.67M |
|
1025
Frontline
FRO
$8.65B
| $2.87M | 0.01% |
+224,525
| New | +$2.45M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.